Biblio Discovery — Demo Discovery Service

5 results for "Allan Relecom"

Showing 1–5 · 0.72 seconds · RSS

  1. Journal Article

    Antibody-Drug Conjugates in the Treatment of Metastatic Breast Cancer: The Emerging Questions of Sequence and Resistance

    Allan Relecom; Francesco Sciotto; Mathieu Chevallier et al.

    healthbook TIMES. Oncology Hematology, Vol. 21 No. 3 · 2024 · English · DOAJ Scopus

    Metastatic breast cancer continues to present significant therapeutic challenges, necessitating ongoing exploration of innovative treatments. The use of antibody-drug conjugates (ADCs) represents an effective treatment strategy that combines the targeting capabilities of monoclonal antibodies with…

  2. Journal Article

    Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity

    Allan Relecom; Maysaloun Merhi; Varghese Inchakalody et al.

    Journal of Experimental & Clinical Cancer Research, Vol. 40 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Immune checkpoint inhibitors provide considerable therapeutic benefit in a range of solid cancers as well as in a subgroup of hematological malignancies. Response rates are however suboptimal, and despite considerable efforts, predicting response to immune checkpoint inhibitors ahead of…

  3. Journal Article

    Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy

    Afsheen Raza; Maysaloun Merhi; Varghese Philipose Inchakalody et al.

    Journal of Translational Medicine, Vol. 18 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Introduction Cancer Immunotherapy has recently emerged as a promising and effective modality to treat different malignancies. Antigenic profiling of cancer tissues and determination of any pre-existing immune responses to cancer antigens may help predict responses to immune intervention in…

  4. Journal Article

    Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy treatment: a case report

    Deepak Kumar; Said Dermime; Maysaloun Merhi et al.

    Journal for ImmunoTherapy of Cancer, Vol. 8 No. 2 · 2020 · English · DOAJ Scopus

    Combined radioimmunotherapy is currently being investigated to treat patients with cancer. Anti-programmed cell death-1 (PD-1) immunotherapy offers the prospect of long-term disease control in solid tumors. Radiotherapy has the ability to promote immunogenic cell death leading to the release of…